182 related articles for article (PubMed ID: 6059730)
21. [Calcium metabolism study performed by means of Ca-45 in bone diseases and idiopathic hypercalciuria].
Renier JC; Bernat M; Jallet P; Gillabert J; Boasson M; Milonas J; Audran M
Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):699-706. PubMed ID: 7455604
[TBL] [Abstract][Full Text] [Related]
22. [Bone metabolism disorders. Pathogenesis and diagnosis].
Fischer JA
Z Orthop Ihre Grenzgeb; 1972 Jun; 110(3):280-92. PubMed ID: 4263211
[No Abstract] [Full Text] [Related]
23. Effects of chlorthalidone and mechanical ventilation on hydroxyprolinuria during immobilization by means of muscle relaxants.
van Kesteren RG; Sangster B; van Heijst AN; Duursma SA
Neth J Med; 1991 Aug; 39(1-2):11-6. PubMed ID: 1835762
[TBL] [Abstract][Full Text] [Related]
24. Partial-body calcium measurements by in vivo neutron activation analysis: comparisons with x-ray photodensitometry measurements of the radius.
Harrison JE; McNeill KG; Meema HE; Fenton S; Oreopoulos DG; Sturtridge WC
J Nucl Med; 1974 Nov; 15(11):929-34. PubMed ID: 4420966
[No Abstract] [Full Text] [Related]
25. Skeletal renewal and metabolic bone disease.
Harris WH; Heaney RP
N Engl J Med; 1969 Jan; 280(4):193-202 contd. PubMed ID: 4302400
[No Abstract] [Full Text] [Related]
26. Biochemistry and radiologic diagnosis of bone disease.
Saville PD
Radiol Clin North Am; 1970 Aug; 8(2):207-14. PubMed ID: 4247690
[No Abstract] [Full Text] [Related]
27. Metabolic studies and 47 Ca kinetics during high calcium intake in senile osteoporosis.
Caniggia A; Gennari C
Helv Med Acta; 1971 Dec; 36(1):43-50. PubMed ID: 5140809
[No Abstract] [Full Text] [Related]
28. [Metabolic bone diseases].
Dequeker J; Van Walleghem U; De Schepper S; Roh YS; Gautama K; Van Dessel D; Burssens A
R I Dent J; 1973; 28(6):390-450. PubMed ID: 4594736
[No Abstract] [Full Text] [Related]
29. [Urinary excretion of hydroxyproline as an index of systemic collagen metabolism].
Drozdz M; Kucharz E
Pol Tyg Lek; 1972 Oct; 27(42):1655-7. PubMed ID: 4564011
[No Abstract] [Full Text] [Related]
30. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
31. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
[TBL] [Abstract][Full Text] [Related]
32. [Hydroxiprolinuria in bone diseases].
Lejeune E; Ruitton P; Meunier P; Orgiazzi J
J Med Lyon; 1970 Jan; 51(179):385-8 passim. PubMed ID: 5526565
[No Abstract] [Full Text] [Related]
33. [The kinetics of Ca45 in functional alterations of the parathyroid glands].
Conte N; Scandellari C; Federspil G
Acta Isot (Padova); 1965 Oct; 5(2):161-71. PubMed ID: 5888043
[No Abstract] [Full Text] [Related]
34. Kinetics of bone metabolism after thyrocalcitonin in man.
Caniggia A; Gennari C
Calcif Tissue Res; 1968; ():Suppl:70. PubMed ID: 5721089
[No Abstract] [Full Text] [Related]
35. [Sodium etidronate (EHDP) and osteoporosis].
Nuti R; Righi G; Turchetti V; Vattimo A
Clin Ter; 1981 Oct; 99(1):33-42. PubMed ID: 6171376
[No Abstract] [Full Text] [Related]
36. [On the metabolic osteology].
Bartelheimer H
Internist (Berl); 1966 Nov; 7(11):551-2. PubMed ID: 4865828
[No Abstract] [Full Text] [Related]
37. [Collagen metabolism in children and adolescents with diseases of the skeletal system].
Balaba TIa; Furtseva LN; Nefed'eva NN
Ortop Travmatol Protez; 1977 Jul; (7):9-15. PubMed ID: 927794
[No Abstract] [Full Text] [Related]
38. [Intestinal absorption of calcium in disorders of calcium metabolism. Results of oral radiocalcium test].
Sadowski P; Klaus D
Med Welt; 1968 Oct; 42():2284-92. PubMed ID: 5730696
[No Abstract] [Full Text] [Related]
39. [Valve and significance of urinary hydroxyproline in osseous pathology].
Hioco D; Gruson M; Ryckewaert A; de Sèze S
Ann Biol Clin (Paris); 1967; 25(5):725-34. PubMed ID: 6059731
[No Abstract] [Full Text] [Related]
40. Applications of the whole-body counter in total-body neutron activation analysis.
Chamberlain MJ; Fremlin JH; Peters DK; Philip H
Br J Radiol; 1970 Apr; 43(508):287-8. PubMed ID: 5442507
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
